X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-15 | SGEN | Dansey Roger D | Pres, R, D, CMO | S - Sale+OE | $199.81 | -10,000 | 96,853 | -9% | -$1,998,115 | |||||
| D | 2023-02-15 | SGEN | Dansey Roger D | Pres, R, D, CMO | S - Sale+OE | $140.64 | -10,000 | 96,853 | -9% | -$1,406,395 | |||||
2023-02-02 | SGEN | Dansey Roger D | Pres, R, D, CMO | S - Sale | $138.52 | -783 | 96,853 | -1% | -$108,461 | ||||||
| D | 2023-01-24 | SGEN | Dansey Roger D | Pres, R, D, CMO | S - Sale+OE | $135.00 | -10,000 | 97,539 | -9% | -$1,350,000 | |||||
| DM | 2023-01-04 | SGEN | Dansey Roger D | Pres R, D, CMO | S - Sale+OE | $135.00 | -10,000 | 97,539 | -9% | -$1,350,000 | |||||
| D | 2022-12-14 | SGEN | Dansey Roger D | Pres, Research, Develo | S - Sale+OE | $135.00 | -10,000 | 97,539 | -9% | -$1,350,000 | |||||
| D | 2022-10-17 | SGEN | Dansey Roger D | Interim CEO, CMO | S - Sale+OE | $135.00 | -10,000 | 97,539 | -9% | -$1,350,000 | |||||
2022-08-31 | SGEN | Dansey Roger D | Interim CEO, CMO | S - Sale | $154.42 | -5,019 | 97,539 | -5% | -$775,006 | ||||||
2022-08-16 | SGEN | Dansey Roger D | Interim CEO, CMO | S - Sale | $170.22 | -4,254 | 102,558 | -4% | -$724,095 | ||||||
| D | 2022-06-28 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale+OE | $180.00 | -34,635 | 62,084 | -36% | -$6,234,300 | |||||
| M | 2022-04-20 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $144.24 | -1,439 | 76,975 | -2% | -$207,565 | |||||
| M | 2022-02-02 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $136.88 | -1,442 | 78,244 | -2% | -$197,378 | |||||
2022-01-03 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $152.58 | -8,675 | 79,686 | -10% | -$1,323,648 | ||||||
| M | 2021-12-20 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $152.72 | -560 | 88,361 | -1% | -$85,520 | |||||
2021-08-31 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $167.52 | -4,611 | 85,339 | -5% | -$772,414 | ||||||
| D | 2021-08-16 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale+OE | $154.55 | -1,657 | 89,950 | -2% | -$256,096 | |||||
2021-08-13 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $156.59 | -10,000 | 74,435 | -12% | -$1,565,867 | ||||||
2021-06-16 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $152.22 | -25,109 | 84,435 | -23% | -$3,822,034 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |